scholarly article | Q13442814 |
P356 | DOI | 10.1080/14728222.2017.1328501 |
P698 | PubMed publication ID | 28490207 |
P50 | author | Yogesh Dwivedi | Q88031898 |
P2093 | author name string | Yogesh Dwivedi | |
P2860 | cites work | Genomic and epigenomic responses to chronic stress involve miRNA-mediated programming | Q21134921 |
MicroRNAs: regulators of neuronal fate | Q24596859 | ||
miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment | Q33864410 | ||
MicroRNA-134 plasma levels before and after treatment for bipolar mania | Q34120739 | ||
MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects | Q34200641 | ||
Biomarker discovery: quantification of microRNAs and other small non-coding RNAs using next generation sequencing | Q35679243 | ||
An overview of microRNAs | Q35858483 | ||
Converging miRNA functions in diverse brain disorders: a case for miR-124 and miR-126. | Q35911210 | ||
Pathogenetic and therapeutic applications of microRNAs in major depressive disorder | Q35956471 | ||
Environmental Intervention as a Therapy for Adverse Programming by Ancestral Stress | Q37435255 | ||
Enoxacin Elevates MicroRNA Levels in Rat Frontal Cortex and Prevents Learned Helplessness | Q37571823 | ||
Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs | Q38068561 | ||
MicroRNA 135 is essential for chronic stress resiliency, antidepressant efficacy, and intact serotonergic activity | Q39266200 | ||
Hippocampal MicroRNA-124 Enhances Chronic Stress Resilience in Mice. | Q39293434 | ||
Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers | Q39293823 | ||
Selective lentiviral-mediated suppression of microRNA124a in the hippocampus evokes antidepressants-like effects in rats | Q42215528 | ||
Polymorphisms in microRNA target sites influence susceptibility to schizophrenia by altering the binding of miRNAs to their targets | Q44426449 | ||
microRNAs as novel antidepressant targets: converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus | Q48007278 | ||
Identification of MicroRNA-124-3p as a Putative Epigenetic Signature of Major Depressive Disorder | Q48043110 | ||
Stress induces region specific alterations in microRNAs expression in mice. | Q48408364 | ||
MicroRNA expression in rat brain exposed to repeated inescapable shock: differential alterations in learned helplessness vs. non-learned helplessness. | Q48922662 | ||
A polymorphism in the microRNA-30e precursor associated with major depressive disorder risk and P300 waveform. | Q49155280 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microRNA | Q310899 |
biomarker | Q864574 | ||
P304 | page(s) | 653-656 | |
P577 | publication date | 2017-05-25 | |
P1433 | published in | Expert Opinion on Therapeutic Targets | Q5421214 |
P1476 | title | microRNA-124: a putative therapeutic target and biomarker for major depression | |
P478 | volume | 21 |
Q51736907 | Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response. |
Q92128332 | Expression alteration of microRNAs in Nucleus Accumbens is associated with chronic stress and antidepressant treatment in rats |
Q47644988 | Macrophage Migration Inhibitory Factor and microRNA-451a in Response to Mindfulness-Based Therapy or Treatment as usual in Patients with Depression, Anxiety or Stress- and Adjustment Disorders |
Q92533559 | MicroRNA-Based Biomarkers in the Diagnosis and Monitoring of Therapeutic Response in Patients with Depression |
Q57129924 | MicroRNAs in depression and suicide: Recent insights and future perspectives |
Q96303296 | The Progress in Diagnosis and Treatment of Exosomes and MicroRNAs on Epileptic Comorbidity Depression |
Q50186746 | The role of microRNAs in glucocorticoid action. |
Q92060033 | miR-138 Increases Depressive-Like Behaviors by Targeting SIRT1 in Hippocampus |
Search more.